Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.03% | -11.07% | -10.99% | 14.58% | -14.21% |
| Total Depreciation and Amortization | -8.36% | 0.10% | 6.43% | -9.37% | 5.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.86% | 455.90% | 226.24% | -100.52% | 130.57% |
| Change in Net Operating Assets | 267.92% | -635.84% | 157.37% | -1,827.21% | 56.40% |
| Cash from Operations | 32.57% | -19.25% | 24.93% | -12.62% | 18.97% |
| Capital Expenditure | -666.29% | -- | -24.63% | -653.85% | 84.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -215.73% | -- | -24.63% | -653.85% | 84.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.81% | 8,272.24% | 11,258.49% | -75.02% | -52.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -96.52% | -- |
| Cash from Financing | 6.81% | 8,272.24% | 11,258.49% | -69.16% | -83.32% |
| Foreign Exchange rate Adjustments | 102.65% | -102.33% | 132.54% | 128.17% | -162.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.36% | 127.66% | 42.23% | -93.18% | -287.35% |